Edesa Biotech (EDSA) Operating Leases (2019 - 2024)
Edesa Biotech's (EDSA) quarterly Operating Leases came in at $19867.0 in Q3 2024, little changed year-over-year from $19773.0 in Q4 2023, and down 48.82% quarter-over-quarter from $38817.0 in Q2 2024.
Powered by 
Analysis
Edesa Biotech (EDSA) Operating Leases (2019 - 2024) Analysis & Trends
Edesa Biotech has disclosed Operating Leases across 6 years of filings, most recently posting $19867.0 for Q3 2024.
- In Q3 2024, Operating Leases changed 0.48% year-over-year to $19867.0; the TTM figure through Sep 2024 stood at $19867.0 (changed 0.48% YoY), while the FY2024 annual figure was $19867.0, changed 0.48% from the prior year.
- Operating Leases came in at $19867.0 for Q3 2024 at Edesa Biotech, down from $38817.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $185439.0 in Q1 2020 to a low of $19773.0 in Q3 2023.
- Average Operating Leases over 5 years is $101057.8, with a median of $99320.0 recorded in 2021.
- Year-over-year, Operating Leases surged 110.97% in 2023 and slumped 66.22% in 2024.
- Over 5 years, Operating Leases stood at $154800.0 in 2020, then tumbled by 48.21% to $80167.0 in 2021, then decreased by 4.42% to $76622.0 in 2022, then advanced by 2.21% to $78314.0 in 2023, then plunged by 74.63% to $19867.0 in 2024.
- Per Business Quant data, the three most recent Operating Leases figures were $19867.0 in Q3 2024, $38817.0 in Q2 2024, and $58143.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.86 Bn | 192.87 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.52 Bn | 176.34 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.47 Bn | 123.62 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.16 Bn | 55.98 Bn | 1.37 Bn |
| 6 | Moderna | 53.15 Bn | 48.02 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.20 Bn | 29.89 Bn | 992.69 Mn |
| 8 | Biogen | 31.65 Bn | 30.37 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.30 Bn | 29.30 Bn | 1.16 Mn |
| 10 | Edesa Biotech | 43.33 Mn | 43.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 19,867.00 |
| Jun 30, 2024 | 38,817.00 |
| Mar 31, 2024 | 58,143.00 |
| Dec 31, 2023 | 78,314.00 |
| Sep 30, 2023 | 19,773.00 |
| Jun 30, 2023 | 114,921.00 |
| Mar 31, 2023 | 129,828.00 |
| Dec 31, 2022 | 76,622.00 |
| Mar 31, 2022 | 61,540.00 |
| Dec 31, 2021 | 80,167.00 |
| Sep 30, 2021 | 99,320.00 |
| Jun 30, 2021 | 121,228.00 |
| Mar 31, 2021 | 138,137.00 |
| Dec 31, 2020 | 154,800.00 |
| Sep 30, 2020 | 164,190.00 |
| Jun 30, 2020 | 176,876.00 |
| Mar 31, 2020 | 185,439.00 |
| Dec 31, 2019 | 218,415.00 |